SeqOne Genomics and Global Diagnostic Solutions Limited (GDS) extend their collaboration in MENA
The companies will participate at the Precision Med Expo Dubai 24th and 25th of May 2022
Montpellier, France – Dubai, May 18, 2022 – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine and Global Diagnostic Solutions Ltd (GDS) today announced their participation in Precision Med Expo Dubai 24th and 25th of May at Conrad Dubai, booth A02.
Precision Medicine Expo has become a major catalyst in the development of personalized medicine in the MENA region. The decision to participate in the event is driven by the belief that huge advances in improving access to personalized medicine in the region can be made given the right solutions. The objective of the two partners at the event is to meet the geneticists, bioinformaticians, biopharma companies and researchers in the region to explore how SeqOne Genomics platform together with GDS support can accelerate the implementation of innovative new personalized medicine programs.
“The MENA region is increasingly committed to personalized medicine with a growing number of national and private sector initiatives,” said Nicolas Phillipe, CEO of SeqOne. “Having a strong local partner like GDS is essential in expanding our presence in the region through collaboration with local healthcare innovators to make genomic testing available to all who need it”.
“We were impressed with SeqOne’s high-performance genomic analysis platform and are proud to represent them in the MENA market” Dr. Mohamed Ramadan, Regional Marketing Head of GDS. “We look forward to supporting local healthcare providers in delivering fast, accurate genomic tests that improve the accessibility of personalized medicine. We look forward to meeting you at Booth: A02.”
About Precision Med Expo.
The Middle East’s Dedicated Precision Medicine Exhibition & Summit provides a vital opportunity for health tech and tech service providers to meet and do business and meet with key decision-makers in healthcare from across the Gulf / Middle East Region. Growing populations, rising life expectancy and changes in lifestyle are leaving a healthcare burden for governments in the Gulf region, they have an urgent need to find smart approaches to tackle the medical needs of their populations.
The Exhibition will take place at the Conrad Hotel Dubai on 24th and 25th of May 2022.
About SeqOne Genomics:
SeqOne Genomics offers high-performance genomic analysis solutions for healthcare providers treating patients suffering from cancer, rare and hereditary diseases as well as pharmaceutical companies developing new therapies. The solution leverages advanced machine learning coupled with the company’s proprietary GeniOS™ genomics operating system to dramatically reduce turnaround times and costs while delivering comprehensive and actionable insights for personalized medicine. The company has won numerous awards including the iLab award and the ARC cancer foundation’s Hélène Stark prize. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes and Software Club. More information at: https://seqone.com
SeqOne Genomics media relations
- Annie-Florence Loyer – email@example.com / +33 (6) 88 20 35 59
- Juliette Milleret – firstname.lastname@example.org /+33 (6) 98 50 21 93
About Global diagnostic solutions Ltd.:
A company with the objective of representing the Molecular Genetics of tomorrow, mapping today’s healthcare through personalized medicines and bioinformatics diagnostics tools with leading European diagnostic companies throughout the MENA Region. We communicate and represent the technology, leading the transformation.
Contact us: (https://gds-eg.com). You can reach us via email: email@example.com